Pulmonary Function in COVID-19 Patients After Discharge

Main Article Content

Shrirang N. Patil
Omkar S. Kulkarni
Aparna P. Patange


Background : The COVID-19 pandemic has affected the whole world. It is now an established fact that the disease affects respiratory system of the victim. In the present study we decided to evaluate pulmonary function of discharged COVID-19 patients (n=335).

Objectives: 1. To carry out Pulmonary function test (Computerised spirometry) in study group and control group. 2. Compare the results between two groups

Methods: Patient’s symptoms & associated co-morbidities were noted during history taking. According to the HRCT scores patients were divided into three groups- mild, moderate & severe. Computerized spirometry was carried out in all these patients and controls(n=300). Pulmonary function test(PFT) parameters from both the groups were analysed.

Results: All the PFT parameter values were very significantly low in subject group compared to those of control group (p <0.000l), except FEF.2-1.2, which was reduced in subject group but not to statistically significant level (p>0.05). Out of total 335 patients 57 had restrictive lung disease, 34 obstructive and 65 had mixed disorder whereas 179 had normal FVC & FEV1. Out of 355 patients, 193(57.62 %) had reduction in PEFR and 142 patients (42.38 %) were having normal PEFR.

Conclusion: It was observed that, reduction occurs in lung function for few months after COVID-19 infection to some extent. It is necessary to follow these patients for a longer period of time, to find out the persistence of derangement in lung function after COVID-19 infection.

Article Details

How to Cite
Shrirang N. Patil, Kulkarni, O. S. ., & Patange, A. P. . (2023). Pulmonary Function in COVID-19 Patients After Discharge. Journal of Coastal Life Medicine, 11(1), 2026–2033. Retrieved from https://www.jclmm.com/index.php/journal/article/view/633


Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Whuan, China.Lancet.2020;395:497-506.

WHO-coronavirus disease (COVID-19) Situation report-137, June5,2020. https://www.who.int/emergiencies/disease/novel-coronvirus-2019/situation-reports. Accessed 16 May2020.

World Health Organization, WHO Coronavirus Disease(COVID-19), 2020. Published on November 29, https://covid19.who.int.

W. Guan, Z. Ni, Y. Hu, W. Liang, C. Ou, J. He, et al. Clinical characteristics of coronavirus disease 2019 in China, N. Engl. J. Med. 382(18) (2020):1708-1720.

5.X Yang, Y Yu, J. Xu, H. Shu, J. Xia, H. Liu, et al. Clinical course and outcome of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study, Lancet Respir. Med.8(5)(2020) 475-481, https://doi.org/10.1016/S2213-2600(20)30079-5.

P. Mehta, D.F. McAuley, M. Brown, E. Sanchez, R.S. Tattersall, J. J. Manson.COVID-19:consider cytokine storm syndromes and immunosuppression, Lancet 395(10219).

Mo X, Jian W, Su Z, Chen M, Peng M, Peng H, Peng P, et al. Abnormal pulmonary function in COVID-19 patients at time of hospital discharge. Eur Respir J. 2020;55:2001217.

Venkatraman T, Frieman MB. The role of epidermal growth factor receptor(EGFR) signaling in SARS corona-virus induced pulmonary fibrosis. Antiviral Res. 2017;143:142-50.

Frija-Masson J, Debray MP, Gilbert M, Lescure FX, Travert F, Borie R, et al. Functional characteristics of patients with SARS-CoV-2 pneumonia at 30 days post infection. Eur Respir J.2020:2001754.

Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, et al. Interpretative strategies for ling function tests. Eur Respir J.2005;26:948-68.

You J, Zhang L, Ni-jia-Ti M, Zhang J, Hu F, Chen L, et al. Abnormal pulmonary function and residual CT abnormalities in rehabilitating COVID-19 patients after discharge, J Infect.2020:2001217.

Saeed GA, Gaba W, Shah A, Al Halali AA, et al. Correlation between Chest CT Severity Scores and the clinical Parameters of Adult Patients with COVID-19 Pneuonia.Radiology Research and Practice Vol.2021, Article ID 6697677,7 pages.https://doi.org/10.1155/2021/6697677.

Miller MR, Hanikson J, Brusasco V, Burgos F, et al. Standardization of Spirometry. Eur Respir J 2005;26:319-338.

Torres-Castro R, Vasconcello-Castillo L, Alsina-Restoy X, Solis-Navarro L, et al. Respiratory function in patients postinfection by COVID-19; A systematic review and metanalysis. J.Pulmoe.Vol.27,Issue 4,Jul-Aug 2021:328-37.

British Thoracic Society. British Thoracic Society Guidance on Respiratory Follow Up of Patients with a Clinico-Radiological Diagnosis of COVID-19 Pneumonia [Internet].2020. Available from: https://www.brit-thoracic.org.uk/document-library/quality-improvement/covid-19/res-follow-up-guidance-post--covid-pneumonia/.

Oriol Sibila, Nuria Albacar, Lidia Perea, Rosa Faner, et al. Lung function sequelae in COVID-19 Patients 3 Months After Hospital Discharge. Letter to the Editor: Arch Bronconeumol.2021;57:45-63.

Guerra S, Sherrill DL, Venker C, Ceccato CM, Halonen M, Martinez FD. Morbidity and mortality associated with the restrictive spirometric pattern: a longitudinal study. Thorax.2010; 65: 499-504.

Scarlata S, Pedone C, Fimognari FL, Bellia V, Forastiere F, Incalzi RA. Restrictive pulmonary dysfunction at spirometry and mortality in the elderly. Respir Med.2008;102:1349-54.

Alessia Fumagalli, Clementia Misuraca, Achille Bianchi, Noemi Borsa, et al. Pulmonary function in patients surviving to COVID-19 pneumonia. Infection: https://doi.org/10.1007/s15010-020-01474-9.

M .S. Wilson and T. A. Wynn. "Pulmonary fibrosis: pathogenesis, etiology and regulation, "Mucosal Immunology, vol.2, no.2,2009: 103-121.

W.T. Huang, H. Akhter, C. Jiang, et al. "Plasminogen activator inhibitor 1, fibroblast apoptosis resistance, and aging-related susceptibility to lung fibrosis, "Experimental Gerontology, vol.61,2015: 62-75.

T. Venkatraman and M.B. Frieman, "The role of epidermal growth factor receptor(EGFR) signaling in SARS coronavirus-induced pulmonary fibrosis, Äntiviral Research,vol.143,2017:142-150.

G.S.Schultz, G. A. Chin, L. Mildawer, and R. F. Diegelmann, "Principles of wound healing,"in Mechanisms of Vascular Disease, A Reference Book for Vascular Specialists, R. Fitridge and M. Thompson, Eds., University of Adelaide Press, Adelaide(AU), 2011.

G. Sagalla, B. Lovene, M. Calri, F. Varone, and L. Richeldi, "Idiopathic pulmonary fibrosis: pathogenesis and management,"Respiratory research, vol.19,no.1,2018:19-32.

Medrinal, C; Prieur, G; Bonnevie, T, et al. Muscle weakness, functional capacities and rescovery for COVID-19 ICU survivors. BMC Anesthesiol 21, 64(2021